Daily Equity Report 03 Sep 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 03 RDSEPTEMBER 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 37068.93 INDIAN EQUITY BENCHMARK - Benchmark indices ended the volatile session on the higher note on the first day of the September series with Nifty above 11,000. At close, the NIFTY 10948.30 Sensex was up 263.86 points at 37,332.79, while Nifty was CLOSE PREVIOUS up 85.60 points at 11,033.90. About 1384 shares have NIKKEI 20460.93 advanced, 1122 shares declined, and 166 shares are unchanged. Bharti Infratel, Coal India, Power Grid, Eicher 25703.50 Motors and ONGC were among major losers on the Nifty, 1967.79 while gainers were Yes Bank, Sun Pharma, IndusInd Bank, SECTORIAL INDICES Zee Entertainment and Tata Steel. Among sectors, except CLOSE energy and infra, other indices ended higher led by the CNX 100 11155.10 pharma, metal, PSU banks, auto, FMCG and IT. GLOBAL FACE S&P CNX 500 ! CNX 200 Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 1.19%, while the BANK NIFTY 27427.85 0.45 Shanghai Composite led the Hang Seng lower. They fell 0.16% and 0.09% respectively. TOP GAINERS CLOSE CHANGE (%) ! U.S. Market – North and South American markets closed sharply higher on Thursday with shares in Brazil leading the YESBANK SUNPHARMA 452.15 region. The Bovespa is up 2.37% while Mexico's IPC is up 2.17% and U.S.'s S&P 500 is up 1.27%. 375.45 ! INDUSINDBK European markets – European markets are broadly higher today with shares in Germany leading the region. The DAX is up 1.05% while France's CAC 40 is up 0.88% and London's TOP LOSERS CLOSE FTSE 100 is up 0.52%. -3.23 COALINDIA -2.28 -1.68 -1.66 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY SELL ON RISE SCRIPT CLOSE (%) 5.23 YESBANK PIVOT POINTS P 10980 S3 10644 S2 10812 S1 R1 11085 R2 11148 RESISTANCE R1-11150 R2-11300 R3 11315 3.32 10917 3.28 SUPPORT S1-10900 S2-10800 JSWSTEEL 218.00 2.85 MARKET MOVERS DOWNSIDE CLOSE (%) -3.23 INFRATEL POWERGRID -1.64 HCLTECH -1.48 -1.17 NET BUY (CR.) NET INSTITUTION SELL (CR) FII 4857.51 TREND STRATEGY SELL ON RISE 4802.11 PIVOT POINTS P 27472 SUPPORT NSE TOTALS S2 26937 S1 27258 R2 R3 28541 DECLINE S 26403 27793 28006 RESISTANCE R1-27800 R2-28000 INDICES BANK NIFTY NIFTY 9 3 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report ! ! September F&O expiry begins on a positive note as value buying emerges HCL Tech's healthcare revenue may be hit due to Opioid lawsuit in US A report said Friday that 48 US states and more than 2,000 local governments have sued drugmakers and retailers for being negligent in marketing and distributing opioids causing an addiction crisis. Purdue Pharma is one such pharma company that is in settlement talks and is expected to pay ~$12bn and file for bankruptcy to become a public trust. Cognizant and HCL Tech are IT services vendors to Purdue Pharma. Allergan and Endo International, distributors McKesson, Cardinal Health, AmerisourceBergen, and retailers such as Walmart, CVS, and RiteAid are also facing lawsuits. Indian equity markets witnessed wild swings on the opening day of the September series as Nifty & Bank Nifty posted strong recoveries in the closing hour of trade. The Nifty Midcap and Bank Nifty indices outperformed the Nifty index by 0.3% as across-the-board buying was witnessed. Further, Nifty Pharma and Nifty FMCG were among the top outperformers closing with ~2% gains, as a majority of their constituents such as Sun Pharma, Dr Reddys, and HUL added heavy long positions with a sharp rise in underlying prices. ! Glenmark Pharma gets USFDA nod for Pimecrolimus Cream Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Pimecrolimus Cream, 1%, a generic version of Elidel Cream, 1%, of Bausch Health US, LLC. According to IQVIA sales data for the 12-month period ending July 2019, the Elidel Cream, 1% market achieved annual sales of approximately $198.8 mn. Glenmarks current portfolio consists of 160 products authorized for distribution in the US marketplace and 55 ANDAs pending approval with the USFDA. ! Adani Green signs agreement to acquire 205 MW solar assets Shares Adani Green Energy Limited (AGEL), on August 29, 2019, post market hours, signed a securities purchase agreement for acquisition of 205 MW operating solar assets of Essel Green Energy Private Limited (EGEPL) and Essel Infraprojects Limited (EIL). The assets are located in Punjab, Karnataka and Uttar Pradesh. All the assets have long term Power Purchase Agreements (PPAs) with various state electricity distribution companies. The portfolio is relatively young with average remaining PPA life of approximately 22 years. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : HDFCAMC DATE : 03/09/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY HDFCAMC IN CASH ABOVE 2552 TGT 2600 SL 2500 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.